UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022153
Receipt number R000025528
Scientific Title A prospective randomized study of the comparison intravesical BCG therapy with intravesical chemotherapy using pirarubicin for non muscle invasive bladder cancer with intermediate recurrent risk
Date of disclosure of the study information 2016/09/01
Last modified on 2016/04/30 16:42:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective randomized study of the comparison intravesical BCG therapy with intravesical chemotherapy using pirarubicin for non muscle invasive bladder cancer with intermediate recurrent risk

Acronym

The comparison intravesical BCG therapy with intravesical chemotherapy using pirarubicin in NMIBC patients

Scientific Title

A prospective randomized study of the comparison intravesical BCG therapy with intravesical chemotherapy using pirarubicin for non muscle invasive bladder cancer with intermediate recurrent risk

Scientific Title:Acronym

The comparison intravesical BCG therapy with intravesical chemotherapy using pirarubicin in NMIBC patients

Region

Japan


Condition

Condition

Bladder Cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The safety of adjuvant intravesical chemotherapy using pirarubicin compared to the intravessical BCG therapy in NMIBC patients with intermediate recurrent risk

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The percentage of adverse effects

Key secondary outcomes

2 Year recurrent free rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intravesical instillation of 80mg BCG , weekly, 6times
Intravesical instillation of 30mg pirarubicin, weekly, 8 times

Interventions/Control_2

The patients were examined by cystoscopy and urine cytological examination every 3 months for 2yeras after intravesical instillationto determine bladder tumor recurrence and every 6 months thereafter. The adverse effects were estimated by CTCAE.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Histologically confirmed urothelial carcinoma
2. Confirmed NMIBC with intermediate recurrent risk
3.Performance status 0-2
4. Patients able to be assessed, e.g., by cystoscopy and urinary cytology, on a regular basis
5. Male or female, aged 20-90 years
6. Patient that given written informed consent prior to the start of this study

Key exclusion criteria

1.Active double cancer (including upper urinary tract carcinoma and prostate carcinoma)
2. CIS, High grade or MIBC confirmed TURBT
3. Previously received BCG intravesical chemotherapy or intravesical chemotherapy within 1 year
4. Serious drug hypersensitivity
5. Active tuberculosis defined by T spot
6. Severe dysfuction of main organs, CHF with NYHA III or IV, asparates aminotransferase and alanine amonotransferase below 3 times as normal values, Hb A1c >= 8.0%
7. Serious viral and bacterial infection
8. Patients the investigators considered to be inappropriate for this study

Target sample size

116


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshi Naya

Organization

Kyoto Prefectural University of Medicine/Meiji University of Integrative Medicine

Division name

Urology

Zip code


Address

465 kajiicho, kamigyo-ku, Kyoto

TEL

0752515595

Email

ynaya@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshio Naya

Organization

Kyoto Prefectural University of Medicine

Division name

Urology

Zip code


Address

465 Kajiicho, kamigyo-ku, Kyoto

TEL

0752515595

Homepage URL


Email

ynaya@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine, Department of Urology

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 06 Month 30 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 30 Day

Last modified on

2016 Year 04 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025528


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name